0001209191-20-026618.txt : 20200501 0001209191-20-026618.hdr.sgml : 20200501 20200501180015 ACCESSION NUMBER: 0001209191-20-026618 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200429 FILED AS OF DATE: 20200501 DATE AS OF CHANGE: 20200501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANG MICHAEL J. CENTRAL INDEX KEY: 0001702283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 20842132 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 3611 VALLEY CENTRE DRIVE,SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-29 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001702283 YANG MICHAEL J. C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, STE. 300 SAN DIEGO CA 92130 0 1 0 0 EVP and CCO Common Stock 2020-04-29 4 M 0 4206 A 6705 D Common Stock 2020-04-30 4 S 0 1501 49.21 D 5204 D Restricted Stock Units 2020-04-29 4 M 0 4206 0.00 D Common Stock 4206 12621 D Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. The restricted stock units vest in four equal annual installments beginning 4/29/2020. /s/ Austin D. Kim, Attorney-in-Fact 2020-05-01